Pharmacologic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

Gastrointestinal Endoscopy Clinics of North America

Volumn 21, Issue 4, 2011, Pages 671-679

  Wu, Justin C Y ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adjunctive therapy; Gastrointestinal bleeding; Pharmacologic therapy; Preemptive therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; OCTREOTIDE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SOMATOSTATIN DERIVATIVE;

COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERANCE; DRUG WITHDRAWAL; ENDOSCOPIC THERAPY; ETHNIC DIFFERENCE; FIBRIN CLOT; GASTRIC ULCER BLEEDING; HEALTH CARE QUALITY; HEMOSTASIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; STOMACH ACID SECRETION; STOMACH PH; ULCER HEALING; UPPER GASTROINTESTINAL BLEEDING;

ERYTHROMYCIN; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HISTAMINE H2 ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS; SOMATOSTATIN; UPPER GASTROINTESTINAL TRACT;

EID: 80053187250     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2011.07.008     Document Type: Review

References (40)

1. Green F.W., Kaplan M.M., Curtis L.E., et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978, 74(1):38-43.
2. Collins R., Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985, 313(11):660-666.
3. Selby N.M., Kubba A.K., Hawkey C.J. Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'. Aliment Pharmacol Ther 2000, 14(9):1119-1126.
4. Levine J.E., Leontiadis G.I., Sharma V.K., et al. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002, 16(6):1137-1142.
5. Merki H.S., Wilder-Smith C.H. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?. Gastroenterology 1994, 106(1):60-64.
6. Lin H.J., Lo W.C., Lee F.Y., et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998, 158(1):54-58.
7. Hasselgren G., Lind T., Lundell L., et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997, 32(4):328-333.
8. Lau J.Y., Sung J.J., Lee K.K., et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000, 343(5):310-316.
9. Javid G., Masoodi I., Zargar S.A., et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001, 111(4):280-284.
10. Sung J.J., Barkun A., Kuipers E.J., et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009, 150(7):455-464.
11. Leontiadis G.I., Sharma V.K., Howden C.W. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006, 1. CD002094.
12. Sung J.J., Lau J.Y., Ching J.Y., et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010, 152(1):1-9.
13. Sung J.J., Chan F.K., Lau J.Y., et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003, 139(4):237-243.
14. Keyvani L., Murthy S., Leeson S., et al. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Aliment Pharmacol Ther 2006, 24(8):1247-1255.
15. Daneshmend T.K., Hawkey C.J., Langman M.J., et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992, 304(6820):143-147.
16. Lau J.Y., Leung W.K., Wu J.C., et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 2007, 356(16):1631-1640.
17. Sreedharan A., Martin J., Leontiadis G.I., et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010, 7. CD005415.
18. Leontiadis G.I., Sharma V.K., Howden C.W. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia-a post hoc analysis from the Cochrane Collaboration. Aliment Pharmacol Ther 2005, 21(9):1055-1061.
19. Oh J.H., Choi M.G., Dong M.S., et al. Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients. J Gastroenterol Hepatol 2007, 22(9):1429-1434.
20. Sugimoto M., Furuta T., Shirai N., et al. Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status. Clin Pharmacol Ther 2006, 80(5):539-548.
21. Andriulli A., Loperfido S., Focareta R., et al. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol 2008, 103(12):3011-3018.
22. Hsu Y.C., Perng C.L., Yang T.H., et al. A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding. Br J Clin Pharmacol 2010, 69(3):245-251.
23. Songur Y., Balkarli A., Acarturk G., et al. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding. Eur J Intern Med 2011, 22(2):200-204.
24. Laine L., McQuaid K.R. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009, 7(1):33-47.
25. Khuroo M.S., Yattoo G.N., Javid G., et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997, 336(15):1054-1058.
26. Jung H.K., Son H.Y., Jung S.A., et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol 2002, 97(7):1736-1740.
27. Murthy S., Keyvani L., Leeson S., et al. Intravenous versus high-dose oral proton pump inhibitor therapy after endoscopic hemostasis of high-risk lesions in patients with acute nonvariceal upper gastrointestinal bleeding. Dig Dis Sci 2007, 52(7):1685-1690.
28. Tsai J.J., Hsu Y.C., Perng C.L., et al. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection. Br J Clin Pharmacol 2009, 67(3):326-332.
29. Laine L., Shah A., Bemanian S. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology 2008, 134(7):1836-1841.
30. Bajaj J.S., Dua K.S., Hanson K., et al. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Dig Dis Sci 2007, 52(9):2190-2194.
31. Bardou M., Toubouti Y., Benhaberou-Brun D., et al. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005, 21(6):677-686.
32. Barkun A.N., Adam V., Sung J.J., et al. Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding. Pharmacoeconomics 2010, 28(3):217-230.
33. Spiegel B.M., Dulai G.S., Lim B.S., et al. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Clin Gastroenterol Hepatol 2006, 4(8):988-997.
34. Imperiale T.F., Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Ann Intern Med 1997, 127(12):1062-1071.
35. Frossard J.L., Spahr L., Queneau P.E., et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology 2002, 123(1):17-23.
36. Coffin B., Pocard M., Panis Y., et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 2002, 56(2):174-179.
37. Carbonell N., Pauwels A., Serfaty L., et al. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol 2006, 101(6):1211-1215.
38. Pateron D., Vicaut E., Debuc E., et al. Erythromycin Infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Ann Emerg Med 2011, 57(6):582-589.
39. Altraif I., Handoo F.A., Aljumah A., et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. Gastrointest Endosc 2011, 73(2):245-250.
40. Winstead N.S., Wilcox C.M. Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. Aliment Pharmacol Ther 2007, 26(10):1371-1377.